BRIEF published on 06/18/2024 at 12:35, 2 years 4 months ago Crossject: Information relating to the total number of voting rights and shares making up the share capital Share Capital Voting Rights AMF Crossject Specialized Pharmacy
BRIEF published on 06/13/2024 at 09:41, 2 years 4 months ago Crossject: Information on the number of voting rights and shares Share Capital Voting Rights Actions 2024 Crossject
BRIEF published on 06/12/2024 at 07:35, 2 years 4 months ago Crossject Appoints Dan Chiche, MD as North America Chief Medical Officer Crossject ZEPIZURE® Dan Chiche Medical Director
PRESS RELEASE published on 06/12/2024 at 07:30, 2 years 4 months ago Crossject appoints Dan Chiche, MD as Chief Medical Officer North America Crossject appoints Dan Chiche, MD as Chief Medical Officer North America, strengthening leadership team and expanding presence in U.S. Supports ZEPIZURE® regulatory milestones targeting in 2025 North America Chief Medical Officer Crossject ZEPIZURE Dan Chiche
BRIEF published on 06/04/2024 at 19:35, 2 years 4 months ago Crossject Announces Successful Closing of €8 Million Rights Offering FDA Approval Rights Offering Crossject ZEPIZURE® Epilepsy Treatment
PRESS RELEASE published on 06/04/2024 at 19:30, 2 years 4 months ago Crossject announces highly successful closing of its €8 million rights offering Crossject successfully closes €8 million rights offering, securing funding for ZEPIZURE® development and FDA approval. Gemmes Venture remains a key supporter FDA Approval Rights Offering Crossject ZEPIZURE® Gemmes Venture
BRIEF published on 05/30/2024 at 10:35, 2 years 5 months ago Crossject: Publication of Clinical Data on ZEPIZURE® Crossject ZEPIZURE® Neurology And Therapy Midazolam Needle-free Injection
PRESS RELEASE published on 05/30/2024 at 10:30, 2 years 5 months ago Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy Crossject announces publication of clinical data on ZEPIZURE in Neurology and Therapy, highlighting bioequivalence versus Dormicum, early onset, and low variability Clinical Data Crossject Neurology And Therapy ZEPIZURE Needle-free Auto-injector
Published on 11/03/2026 at 08:00, 3 hours 59 minutes ago Caledonia Mining Corporation Plc Notice of Q3 2026 Results and Investor Presentation
Published on 11/02/2026 at 23:15, 12 hours 44 minutes ago ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 13 hours 29 minutes ago Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 18 hours 59 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/03/2026 at 11:30, 28 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover offer – Satisfaction of all closing conditions
Published on 11/03/2026 at 11:30, 28 minutes ago SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Published on 11/03/2026 at 11:20, 38 minutes ago BOC Group Named a Leader in Gartner® Magic Quadrant™ for Enterprise Architecture Tools 2026
Published on 11/03/2026 at 10:35, 1 hour 23 minutes ago Pudu Robotics Unveils PUDU TOMO S Series: Extending Lawn Care Automation to Blade Sharpening
Published on 11/03/2026 at 10:35, 1 hour 23 minutes ago New AI transformation company raises funding to advance AI adoption in Europe
Published on 11/03/2026 at 07:00, 4 hours 59 minutes ago bioMérieux – Third-Quarter 2026 Business Review
Published on 11/02/2026 at 18:30, 17 hours 29 minutes ago Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 17 hours 41 minutes ago Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 17 hours 59 minutes ago Covivio - Information on total number of voting rights and share capital
